Provided by Tiger Trade Technology Pte. Ltd.

Roivant Sciences Ltd.

40.18
+0.61001.54%
Volume:1.88M
Turnover:76.42M
Market Cap:29.03B
PE:-85.49
High:40.97
Open:40.45
Low:40.07
Close:39.57
52wk High:42.50
52wk Low:14.50
Shares:722.41M
Float Shares:581.00M
Volume Ratio:1.02
T/O Rate:0.32%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.4700
EPS(LYR):-0.5400
ROE:-8.52%
ROA:-16.48%
PB:6.86
PE(LYR):-74.41

Loading ...

Roivant President, CIO Mayukh Sukhatme Disposes of Common Shares Worth $34.1 Million

Reuters
·
Jun 30

Immunovant Director Atul Pande Disposes of 1,500 Common Shares for $57,015

Reuters
·
Jun 27

Roivant Sciences President and Immunovant CEO Eric Venker Disposes of Common Shares Worth $6.63 Million

Reuters
·
Jun 27

Immunovant director Atul Pande disposes of USD 51,030 common shares

Reuters
·
Jun 17

Piper Sandler Sticks to Their Buy Rating for Roivant Sciences (ROIV)

TIPRANKS
·
Jun 16

Immunovant director Andrew J. Fromkin reports common share disposal worth $7.44 million

Reuters
·
May 30

Roivant Sciences Is Maintained at Buy by Guggenheim

Dow Jones
·
May 26

Analysts Offer Insights on Healthcare Companies: Roivant Sciences (ROIV), Crescent Biopharma (CBIO) and Genmab (GMAB)

TIPRANKS
·
May 26

Roivant Sciences price target raised to $31.50 from $29.50 at BofA

TIPRANKS
·
May 25

Roivant President, Immunovant CEO Eric Venker disposes common shares worth $7.23 million

Reuters
·
May 23

Should Roivant’s One‑Off Driven Profitability Shift Require Action From Roivant Sciences (ROIV) Investors?

Simply Wall St.
·
May 22

Roivant Sciences Price Target Maintained With a $34.00/Share by HC Wainwright & Co.

Dow Jones
·
May 21

Analysts Offer Insights on Healthcare Companies: Incyte (INCY), Kindly MD (NAKA) and Roivant Sciences (ROIV)

TIPRANKS
·
May 21

Roivant Sciences Ltd : Leerink Partners Raises Target Price to $42 From $38

THOMSON REUTERS
·
May 21

Immunovant director Atul Pande disposes 6,000 shares for $192,000

Reuters
·
May 21

BUZZ-U.S. STOCKS ON THE MOVE-Nvidia, Hasbro, Micron

Reuters
·
May 21

Stock Track | Roivant Sciences Soars 15.99% Intraday on Unexpected Q4 Profit and Promising Arthritis Drug Data

Stock Track
·
May 21

Roivant Sciences rises 15.2%

TIPRANKS
·
May 21

BUZZ-U.S. STOCKS ON THE MOVE-Royal Caribbean Cruises, AMC Entertainment, Roivant

Reuters
·
May 20

2 Biotech Stocks Are Surging Today Thanks to This Arthritis Drug -- Barrons.com

Dow Jones
·
May 20